Methylation profiling

Dataset Information

0

MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells


ABSTRACT: The steroid co-activator protein SRC-1 plays an important role in endocrine therapy resistant breast cancer. Its expression is associated with large high grade tumours, HER2 positivity, disease recurrence and resistance to endocrine therapy. While SRC-1 typically functions to activate gene expression, some evidence has pointed towards a potential role in repression. This study looks into the effects of a stable knockdown of SRC-1 in a tamoxifen resistant cell line, LY2, and the effects of this knock down on the methylation landscape.

ORGANISM(S): Homo sapiens

PROVIDER: GSE99648 | GEO | 2018/06/04

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2018-06-04 | GSE99647 | GEO
2014-01-14 | E-GEOD-54027 | biostudies-arrayexpress
2014-01-14 | GSE54027 | GEO
2011-11-01 | E-GEOD-28987 | biostudies-arrayexpress
2014-09-18 | E-MTAB-1870 | biostudies-arrayexpress
2011-03-30 | GSE28267 | GEO
2011-03-30 | E-GEOD-28267 | biostudies-arrayexpress
2011-11-01 | GSE28987 | GEO
2023-05-16 | GSE176533 | GEO
| PRJNA389208 | ENA